Beleave Provides Update on B.C. Indoor Facilities

This information was provided by PRNewswire

Send your Press Release here.

TORONTO, Oct 1, 2018 /CNW/ – Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company“) is pleased to announce that it is has filed an application with Health Canada and, once approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation cannabis project in British Columbia.

Less than two weeks ago, the Company announced the ambitious new project, jointly-designed by Beleave and Kannavis Biotech Corp., on a 50/50 operating expenditure and revenue partnership, that will encompass a total of ten indoor growing facilities approximately 87,000 square feet each.

This project is fully capitalized and will carry newest products including strains of cannabis not yet offered in Canada, as well processing of newly acquired and developed products that will include edibles, drinks, and other non-combustible cannabis products that Beleave will be releasing to the general public in the near future.

“We’re very pleased with our progress, and we anticipate receiving the approval from Health Canada,” said Andrew Wnek, Beleave CEO. “Once completed, the entire project will add hundreds of thousands of square feet of superior indoor grow space to our growing capacity. We will continue to update our stakeholders on its progress as developments arise.”

The company plans to have phase one fully built, outfitted, and producing cannabis for Q2 2019.

Emerald contributor since March 2012

Comments

Your email address will not be published.